Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Biochemistry|May 23, 1995
Protein farnesyltransferase: kinetics of farnesyl pyrophosphate binding and product releaseE S Furfine, J J Leban, A Landavazo, et al.Antiviral Research|July 13, 2001
Metabolic complications associated with antiretroviral therapyR G Jain, E S Furfine, L Pedneault, et al.The Journal of Biological Chemistry|February 5, 1993
Biochemical analysis of human immunodeficiency virus-1 reverse transcriptase containing a mutation at position lysine 263J L Martin, J E Wilson, E S Furfine, et al.Life Sciences|January 1, 1997
Potent inhibition of human neuronal nitric oxide synthase by N(G)-nitro-L-arginine methyl ester results from contaminating N(G)-nitro-L-arginineE S Furfine, K Carbine, S Bunker, et al.Biochemistry|September 12, 2001
Effectors of HIV-1 protease peptidolytic activityD J Porter, M H Hanlon, L H Carter, et al.Biochemistry|September 1, 1992
Two-step binding mechanism for HIV protease inhibitorsE S Furfine, E D'Souza, K J Ingold, et al.The Journal of Nutrition|August 26, 2000
Dietary fat alters HIV protease inhibitor-induced metabolic changes in miceJ M Lenhard, D K Croom, J E Weiel, et al.Journal of Medicinal Chemistry|June 6, 1997
Substituted N-phenylisothioureas: potent inhibitors of human nitric oxide synthase with neuronal isoform selectivityB G Shearer, S Lee, J A Oplinger, et al.The Journal of Biological Chemistry|December 27, 1996
Human immunodeficiency virus. Mutations in the viral protease that confer resistance to saquinavir increase the dissociation rate constant of the protease-saquinavir complexB Maschera, G Darby, G Palú, et al.The Journal of Biological Chemistry|February 21, 1997
1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivoE P Garvey, J A Oplinger, E S Furfine, et al.Pageof 3